Esreboxetine
Esreboxetine is a selective norepinephrine reuptake inhibitor which was under development by Pfizer for the treatment of neuropathic pain and fibromyalgia but failed to show significant benefit over currently available medications and was discontinued.
EsreboxetineC19H23NO3List of drugs: Eq-EsEdivoxetineList of adrenergic drugsNorepinephrine reuptake inhibitor
Share this!